The National Cancer Institute (NCI) is offering this grant to support exploratory research for the early-stage development of highly innovative technologies. This funding opportunity focuses on novel molecular or cellular analysis capabilities crucial for basic and clinical cancer research. The emphasis is on developing new capabilities to target, probe, or assess molecular and cellular features of cancer biology with high technical innovation. While technologies may have widespread applicability, their core purpose must be to improve molecular and/or cellular characterizations of cancer. This grant is for projects with the potential to accelerate and enhance research in areas such as cancer biology, early detection, diagnosis, treatment, control, epidemiology, and addressing cancer health disparities. It is part of the NCI’s broader Innovative Molecular Analysis Technologies (IMAT) Program.
Opportunity ID: 344760
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-23-002 |
| Funding Opportunity Title: | Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 02, 2022 |
| Last Updated Date: | Dec 02, 2022 |
| Original Closing Date for Applications: | Sep 01, 2023 |
| Current Closing Date for Applications: | Sep 01, 2023 |
| Archive Date: | Oct 07, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Public and State controlled institutions of higher education City or township governments Public housing authorities/Indian housing authorities Private institutions of higher education Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses For profit organizations other than small businesses Native American tribal governments (Federally recognized) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. The emphasis of this FOA is on supporting the development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology. Technologies proposed for development may be intended to have widespread applicability but must be focused on improving molecular and/or cellular characterizations of cancer biology. Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities.This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-002.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278766 | Feb 01, 2023 | Sep 01, 2023 | View |
Package 1
Mandatory forms
344760 RR_SF424_5_0-5.0.pdf
344760 PHS398_CoverPageSupplement_5_0-5.0.pdf
344760 RR_OtherProjectInfo_1_4-1.4.pdf
344760 PerformanceSite_4_0-4.0.pdf
344760 RR_KeyPersonExpanded_4_0-4.0.pdf
344760 RR_Budget_3_0-3.0.pdf
344760 PHS398_ResearchPlan_5_0-5.0.pdf
344760 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
344760 RR_SubawardBudget30_3_0-3.0.pdf
344760 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
